SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039314
Filing Date
2020-08-11
Accepted
2020-08-11 16:13:46
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-10q_20200630.htm 10-Q 1623757
2 EX-10.2 alt-ex102_335.htm EX-10.2 12041
3 EX-10.3 alt-ex103_571.htm EX-10.3 33185
4 EX-31.1 alt-ex311_6.htm EX-31.1 18167
5 EX-31.2 alt-ex312_7.htm EX-31.2 17900
6 EX-32.1 alt-ex321_8.htm EX-32.1 6184
7 EX-32.2 alt-ex322_9.htm EX-32.2 6138
8 GRAPHIC gxgpyldmzs5j000001.jpg GRAPHIC 5426
  Complete submission text file 0001564590-20-039314.txt   6079070

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alt-20200630.xml EX-101.INS 1181541
10 XBRL TAXONOMY EXTENSION SCHEMA alt-20200630.xsd EX-101.SCH 50595
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20200630_cal.xml EX-101.CAL 55403
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20200630_def.xml EX-101.DEF 158050
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20200630_lab.xml EX-101.LAB 410479
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20200630_pre.xml EX-101.PRE 313039
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 201092571
SIC: 2834 Pharmaceutical Preparations